InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,671.20
(
0.15%
)
Dow Jones
39,308.00
(
0.00%
)
Brent Oil
87.14
(
-0.22%
)
Bitcoin
55,428.96
(
-2.72%
)
Post# of 252487
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

iwfal

Send PM Follow Ignore
Followers 75
Posts 4693
Boards Moderated 0
Alias Born 09/06/2003

iwfal

Member Level

Re: bladerunner1717 post# 150574

Monday, 10/15/2012 3:54:46 PM

Monday, October 15, 2012 3:54:46 PM

Post# of 252487
ABT HCV results:

Agreed that these look good - but:

a) Reminder that previous data indicated that for an ABT all-oral regimen (this one?) the post treatment relapse rate was much greater than one would expect from an ifn based treatment - even past 24 weeks.


b) I'd like to see a breakout of G1a vs G1b

In combo I would guess there is still substantial room for improvement in one of the G1 subtypes.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up